在药物结合部位的解码疗效和耐药空间
Simone Altmann1, Cesar Mendoza-Martinez1,2, Melanie Ridgway1
1Wellcome Centre for Anti-Infectives Research, Faculty of Life Sciences, University of Dundee, Dundee, UK.
Nature communications
|February 4, 2026
概括
这项研究通过使用多重基向和计算建模在结合部位分析所有突变来解码耐药性. 这种方法揭示了突变适应性的广泛约束,并预测了耐药性途径.
科学领域:
- 药物的发现和开发.
- 计算生物学是一种计算生物学.
- 寄生虫学的寄生虫学
背景情况:
- 了解耐药性机制对于开发有效治疗方法至关重要.
- 在药物结合部位评估所有可能突变的影响在计算和实验上具有挑战性.
- 蛋白质体是有效的药物标,用于治疗寄生虫疾病,如试.
研究的目的:
- 解码一种抗试osomal蛋白酶体抑制剂的疗效和耐药性格局.
- 评估在药物结合部位的所有可能突变的影响.
- 开发一种药物耐药性的预测模型.
主要方法:
- 多重复合的基向和突变发生在Trypanosoma brucei蛋白质组中的20个编码体.
- 逐步选择药物和编码体变异得分,以生成突变物剂量反应概况.
- 计算机建模和突变影响的in silico预测.
- 适应性分析以确定对突变适应性的限制.
主要成果:
- 识别了100多种传递耐药性的突变,具有详细的剂量反应概况.
- 科登变种得分准确地预测了相对抗药性.
- 健身分析揭示了突变性健身和抵抗空间的广泛限制.
- 在 silico 预测与实验中观察到的纤维素药物耐药性密切结合.
结论:
- 多重基向是评估药物结合部位的所有可能突变的有效方法.
- 这项研究提供了一个全面的了解,对抗三体蛋白酶体抑制剂的耐药性景观.
- 这些发现有助于预测药物耐药性路径,并为下一代治疗方法的开发提供信息.
更多相关视频
11:56Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
14.7K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.6K
相关概念视频
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
486
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
486
01:24Tissue-Drug Binding: Localization of Drugs and its Significance
445
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
445
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
605
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
605
01:21Drug Distribution: Tissue Binding
4.1K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
4.1K
01:30Drug Binding to Blood Components
533
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
533
01:29Drug Distribution: Plasma Protein Binding
8.9K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.9K